{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:17:21Z","timestamp":1778581041894,"version":"3.51.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03133","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:04:41Z","timestamp":1547107481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Kai","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","article-title":"The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis","volume":"223","author":"Noss","year":"2008","journal-title":"Immunol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nrrheum.2016.63","article-title":"Rheumatoid arthritis: features of synovium in RA remission revealed","volume":"12","author":"Collison","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/2326-6066.CIR-16-0061-T","article-title":"Dasatinib changes immune cell profiles concomitant with reduced tumor growth in several murine solid tumor models","volume":"5","author":"Hekim","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40265-016-0677-x","article-title":"Dasatinib: a review in chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/DDDT.S80207","article-title":"The role of dasatinib in the management of chronic myeloid leukemia","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des Devel Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/B978-0-12-800173-8.00004-0","article-title":"Dasatinib","volume":"39","author":"Korashy","year":"2014","journal-title":"Profiles Drug Subst Excip Relat Methodol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1172\/JCI28546","article-title":"Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis","volume":"116","author":"Paniagua","year":"2006","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/s10165-010-0392-5","article-title":"Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis","volume":"21","author":"Akashi","year":"2011","journal-title":"Mod Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1124\/dmd.109.031302","article-title":"Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib","volume":"38","author":"Dohse","year":"2010","journal-title":"Drug Metab Dispos."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/ijc.25233","article-title":"The BCR\/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity","volume":"127","author":"Salih","year":"2010","journal-title":"Int J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00011-018-1176-1","article-title":"Quetiapine ameliorates collagen-induced arthritis in mice via the suppression of the AKT and ERK signaling pathways","volume":"67","author":"Pan","year":"2018","journal-title":"Inflamm Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13218","article-title":"Blocking of YY1 reduce neutrophil infiltration by inhibiting IL 8 production via the PI3K-Akt-mTOR signaling pathway in rheumatoid arthritis","author":"Lin","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm.3026","article-title":"miR-214 targets ATF4 to inhibit bone formation","volume":"19","author":"Wang","year":"2013","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.05.010","article-title":"11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis","volume":"92","author":"Hardy","year":"2018","journal-title":"J Autoimmun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm1304","article-title":"Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors","volume":"11","author":"Deng","year":"2005","journal-title":"Nat Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e171169","DOI":"10.1371\/journal.pone.0171169","article-title":"Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)","volume":"12","author":"Qian","year":"2017","journal-title":"PLOS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.112.192195","article-title":"Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032)","volume":"342","author":"Mittapalli","year":"2012","journal-title":"J Pharmacol Exp Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12185-016-2137-5","article-title":"Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia","volume":"105","author":"Morita","year":"2016","journal-title":"Int J Hematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/cmdc.201600387","article-title":"Design, synthesis, and evaluation of dasatinib-amino acid and dasatinib-fatty acid conjugates as protein tyrosine kinase inhibitors","volume":"12","author":"Tiwari","year":"2017","journal-title":"Chemmedchem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mce.2015.08.012","article-title":"The Src non-receptor tyrosine kinase paradigm: new insights into mammalian Sertoli cell biology","volume":"415","author":"Chojnacka","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1093\/hmg\/ddv254","article-title":"Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin","volume":"24","author":"McDonell","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2008.09.010","article-title":"Tyrosine kinases as targets in rheumatoid arthritis","volume":"9","author":"Tristano","year":"2009","journal-title":"Int Immunopharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/13543784.2016.1182499","article-title":"Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis","volume":"25","author":"Norman","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/art.39116","article-title":"Role of EFNB1 and EFNB2 in mouse collagen-induced arthritis and human rheumatoid arthritis","volume":"67","author":"Hu","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2009.82","article-title":"Tyrosine kinases as targets for the treatment of rheumatoid arthritis","volume":"5","author":"D'Aura","year":"2009","journal-title":"Nat Rev Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/15680266113139990094","article-title":"Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis","volume":"13","author":"Gomez-Puerta","year":"2013","journal-title":"Curr Top Med Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.leukres.2007.11.008","article-title":"Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines","volume":"32","author":"Deguchi","year":"2008","journal-title":"Leuk Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jbspin.2015.11.009","article-title":"GC\/TOF-MS-based metabolomic profiling in cultured fibroblast-like synoviocytes from rheumatoid arthritis","volume":"83","author":"Ahn","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejphar.2016.10.004","article-title":"Hesperidin derivative-11 inhibits fibroblast-like synoviocytes proliferation by activating Secreted frizzled-related protein 2 in adjuvant arthritis rats","volume":"794","author":"Liu","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3892\/ijmm.2016.2755","article-title":"Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1","volume":"38","author":"Pan","year":"2016","journal-title":"Int J Mol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e34914","DOI":"10.1371\/journal.pone.0034914","article-title":"Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects","volume":"7","author":"Garcia-Gomez","year":"2012","journal-title":"PLOS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/jbmr.85","article-title":"The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo","volume":"25","author":"Vandyke","year":"2010","journal-title":"J Bone Miner Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/aps.2012.187","article-title":"Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol Sin."},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00011-015-0905-y","article-title":"CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2\/STAT3 and p38\/MAPK signaling pathway","volume":"65","author":"Li","year":"2016","journal-title":"Inflamm Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14715\/cmb\/2016.62.13.8","article-title":"Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1beta-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"62","author":"Wang","year":"2016","journal-title":"Cell Mol Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0757.2006.00185.x","article-title":"Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease","volume":"43","author":"Nagasawa","year":"2007","journal-title":"Periodontol 2000"},{"key":"B42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3899\/jrheum.100089","article-title":"Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis","volume":"38","author":"Wang","year":"2011","journal-title":"J Rheumatol."},{"key":"B45","first-page":"77","article-title":"In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density","volume":"33","author":"Rossini","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/rheumatology\/kev422","article-title":"Activation of dickkopf-1 and focal adhesion kinase pathway by tumour necrosis factor alpha induces enhanced migration of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"55","author":"Choe","year":"2016","journal-title":"Rheumatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.exphem.2009.09.007","article-title":"Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo","volume":"37","author":"Fraser","year":"2009","journal-title":"Exp Hematol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/08923973.2015.1028074","article-title":"Therapeutic effects of dasatinib in mouse model of multiple sclerosis","volume":"37","author":"Azizi","year":"2015","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1042\/BJ20141165","article-title":"The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases","volume":"465","author":"Ozanne","year":"2015","journal-title":"Biochem J."},{"key":"B50","first-page":"133","article-title":"Regular expression of discoidin domain receptor 2 in the improved adjuvant-induced animal model for rheumatoid arthritis","volume":"20","author":"Li","year":"2005","journal-title":"Chin Med Sci J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-009-0127-0","article-title":"Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis","volume":"330","author":"Su","year":"2009","journal-title":"Mol Cell Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0925-4439(00)00056-9","article-title":"Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts","volume":"1502","author":"Moore","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08916930600807709","article-title":"The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis","volume":"39","author":"Wernicke","year":"2006","journal-title":"Autoimmunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2013a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","article-title":"Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?","volume":"10","author":"Marrelli","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/path.4311","article-title":"A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis","volume":"232","author":"Zhang","year":"2014","journal-title":"J Pathol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:04:44Z","timestamp":1547107484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2018.03133"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03133","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"article-number":"3133"}}